"Vaccines, Synthetic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified.
Descriptor ID |
D014614
|
MeSH Number(s) |
D12.776.828.868 D20.215.894.865 D23.050.865
|
Concept/Terms |
Vaccines, Synthetic- Vaccines, Synthetic
- Synthetic Vaccines
- Synthetic Immunogens
- Immunogens, Synthetic
Molecular Vaccines- Molecular Vaccines
- Vaccines, Molecular
- Vaccines, Chemical
- Chemical Vaccines
|
Below are MeSH descriptors whose meaning is more general than "Vaccines, Synthetic".
Below are MeSH descriptors whose meaning is more specific than "Vaccines, Synthetic".
This graph shows the total number of publications written about "Vaccines, Synthetic" by people in this website by year, and whether "Vaccines, Synthetic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 1 | 3 |
1995 | 3 | 1 | 4 |
1996 | 9 | 3 | 12 |
1997 | 2 | 5 | 7 |
1998 | 3 | 2 | 5 |
1999 | 4 | 1 | 5 |
2000 | 3 | 3 | 6 |
2001 | 1 | 2 | 3 |
2002 | 2 | 4 | 6 |
2003 | 4 | 3 | 7 |
2004 | 2 | 6 | 8 |
2005 | 2 | 5 | 7 |
2006 | 2 | 3 | 5 |
2007 | 3 | 4 | 7 |
2008 | 1 | 4 | 5 |
2009 | 0 | 5 | 5 |
2010 | 2 | 4 | 6 |
2011 | 2 | 1 | 3 |
2012 | 1 | 7 | 8 |
2013 | 0 | 3 | 3 |
2014 | 2 | 5 | 7 |
2015 | 1 | 6 | 7 |
2016 | 0 | 8 | 8 |
2017 | 2 | 7 | 9 |
2018 | 2 | 3 | 5 |
2019 | 0 | 1 | 1 |
2020 | 1 | 6 | 7 |
2021 | 5 | 9 | 14 |
2022 | 1 | 14 | 15 |
2023 | 0 | 1 | 1 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vaccines, Synthetic" by people in Profiles.
-
A Journey in Science: Molecular vaccines for global child health in troubled times of anti-science. Mol Med. 2024 Mar 15; 30(1):37.
-
Broad protective vaccination against systemic Escherichia coli with autotransporter antigens. PLoS Pathog. 2023 02; 19(2):e1011082.
-
Recombinant zoster vaccine (RZV) second-dose series completion in adults aged 50-64 years in the United States. Vaccine. 2022 Nov 28; 40(50):7187-7190.
-
mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients. J Infect Dis. 2022 09 13; 226(5):797-807.
-
Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States. JAMA Netw Open. 2022 09 01; 5(9):e2233273.
-
Effectiveness of mRNA COVID-19 vaccines against Omicron and Delta variants in a matched test-negative case-control study among US veterans. BMJ Open. 2022 08 03; 12(8):e063935.
-
Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential. PLoS Pathog. 2022 06; 18(6):e1010658.
-
Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants. N Engl J Med. 2022 07 14; 387(2):109-119.
-
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant. Cell Rep Med. 2022 07 19; 3(7):100679.
-
Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccine. Nat Commun. 2022 06 16; 13(1):3466.